Winthrop Partners - WNY’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Winthrop Partners - WNY's AMGN Position: Q3 2019 in Review
Winthrop Partners - WNY reduced its Amgen (AMGN) stake by 5% in Q3 2019, selling an estimated $6.53K and leaving 650 shares worth $126K. The position accounts for 0.09% of the portfolio, ranked #134.
Winthrop Partners - WNY first reported a position in AMGN in Q4 2017 and has held it in 8 quarters since. The position peaked at $226K in Q4 2017. 1,883 funds tracked by Wall St. Rank hold AMGN as of Q3 2019.
- Winthrop Partners - WNY held 650 shares of Amgen worth $126K as of Q3 2019.
- Winthrop Partners - WNY sold 34 Amgen shares in Q3 2019, an estimated $6.53K.
- Amgen made up 0.09% of Winthrop Partners - WNY's portfolio in Q3 2019, its #134 holding.
- Winthrop Partners - WNY first reported a position in Amgen in Q4 2017 and has held it in 8 quarters since.
- Winthrop Partners - WNY's Amgen position peaked at $226K in Q4 2017.
- 1,883 funds tracked by Wall St. Rank held Amgen as of Q3 2019.
Based on Winthrop Partners - WNY's 13F filing for Q3 2019, filed 28 Oct 2019.